DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Haemoglobin Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Haemoglobin Decreased (112)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include haemoglobin decreased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 112   Next >>

Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Protonix



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-11

Rebetol
    Dosage: unk

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-16

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-06-24

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-16
    End date: 2012-07-02

Telavic
    Dosage: 1000 unk, unk
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-09

Other drugs received by patient: Valsartan and Hydrochlorothiazide



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3 microgram per kilogram, qw
    Start date: 2012-06-01

PEG-Intron
    Dosage: 1.7 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-25

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-29

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-17

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-07

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-22
    End date: 2012-06-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-05-31

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-31

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-06-22
    End date: 2012-07-18



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Hepatic Function Abnormal, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-30

Incivek
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-30

PEG-Intron
    Dosage: 1.2mcg/kg/week
    Start date: 2012-03-23

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-03-22

PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    End date: 2012-05-04

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-20

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-05-11

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-04-19

Other drugs received by patient: Branute; Allegra; Selbex; Loxoprofen; Posterisan; Posterisan; Heparinoid; Flurbiprofen; Branute; Hirudoid; Livostin; Flurbiprofen; Livostin; Allegra



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Renal Impairment, Pericardial Effusion

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-03-09

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-03-08

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-01-20
    End date: 2012-07-06

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-20

Rebetol
    Administration route: Oral
    Start date: 2012-06-29
    End date: 2012-07-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-10
    End date: 2012-03-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-02-09

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-03-15

Rebetol
    Dosage: 200mg/every other day
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-05-24

Rebetol
    Dosage: 200 mg, unknown
    Administration route: Oral
    Start date: 2012-03-30

Telavic
    Administration route: Oral
    Start date: 2012-03-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-03-08

Other drugs received by patient: Urso 250; Celebrex; Cerekinon; [therapy Unspecified]; Calcium Chloride (+) Potassium Chloride (+) Sodium Chloride (+) Sodium; Voltaren; Nexium; Heparinoid; Cerekinon; Hirudoid; Nexium; Celecoxib; Heparinoid; Allopurinol; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron

Rebetol

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Administration route: Oral

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Gasmotin; Nizatidine; Motilium



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-25
    End date: 2012-05-31

PEG-Intron
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-06-01

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-22

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-25
    End date: 2012-06-21

Rebetol
    Dosage: unk

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-25



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Pancreatitis Acute, Haemoglobin Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.54 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-02-03

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-02-16

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-02-17
    End date: 2012-03-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-04-06

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-07
    End date: 2012-04-20

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-04-20

Other drugs received by patient: Norvasc; Olmesartan Medoxomil



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Bone Marrow Failure, Neutrophil Count Decreased

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-26
    End date: 2012-06-04

PEG-Intron
    Indication: Hepatitis C

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-26
    End date: 2012-06-04

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-26
    End date: 2012-06-04

Rebetol
    Indication: Hepatitis C

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26
    End date: 2012-06-04

Other drugs received by patient: Primperan TAB; LAC-B; Evamyl; Allopurinol



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Hypothyroidism, Pyrexia, Neutrophil Count Decreased

Drug(s) suspected as cause:
Interferon Beta NOS
    Dosage: 6 million iu, tiw
    Start date: 2010-11-17
    End date: 2011-09-16

Interferon Beta NOS
    Dosage: 6 million iu, qd
    Indication: Hepatitis C
    Start date: 2010-10-18
    End date: 2010-11-15

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2010-11-22
    End date: 2011-09-16

Rebetol
    Dosage: 200mg 400mg in evening in morning
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-10-18
    End date: 2010-11-21

Other drugs received by patient: Mucosta; Mucosta; Pegasys



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Blood Urea Increased, Blood Uric Acid Increased, Blood Creatinine Increased

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-18
    End date: 2012-05-21

PEG-Intron
    Dosage: 0.75mcg/kg/week
    Start date: 2012-06-15
    End date: 2012-06-15

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-18
    End date: 2012-06-07

PEG-Intron
    Dosage: 1.5 ?g/kg, unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-18

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-06-19

Rebetol
    Administration route: Oral
    Start date: 2012-06-15

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-18
    End date: 2012-06-14

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-18
    End date: 2012-05-21

Telavic
    Administration route: Oral
    Start date: 2012-05-26



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Neutrophil Count Decreased, Hyperuricaemia

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram qw
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-13

Peginterferon Alfa-2B
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-07-03
    End date: 2012-07-10

Peginterferon Alfa-2B
    Dosage: 0.43 microgram per kilogram, qw
    Start date: 2012-04-10
    End date: 2012-04-10

Peginterferon Alfa-2B
    Dosage: 0.6 microgram per kilogram, qw
    Start date: 2012-04-17
    End date: 2012-05-01

Peginterferon Alfa-2B
    Dosage: 0.43 microgram per kilogram, qw
    Start date: 2012-05-15
    End date: 2012-06-26

Peginterferon Alfa-2B
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-05-08
    End date: 2012-05-08

Peginterferon Alfa-2B
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-04-03
    End date: 2012-04-03

Peginterferon Alfa-2B
    Dosage: 0.86 microgram per kilogram, qw
    Start date: 2012-07-17

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-05

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-04-30

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-03
    End date: 2012-04-23

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-18

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-06
    End date: 2012-03-12

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-05-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-18

Telavic
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-03
    End date: 2012-04-16

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-05-08

Other drugs received by patient: Urso 250; Amlodipine; Olmesartan Medoxomil; Olmesartan Medoxomil; Nesina; Confatanin; Posterisan Forte; Clobetasol Propionate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Anaemia, Renal Tubular Necrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.9mcg/kg/week
    Start date: 2012-06-21
    End date: 2012-06-21

PEG-Intron
    Dosage: 1.8mcg/kg/week
    Start date: 2012-05-08
    End date: 2012-06-20

PEG-Intron
    Dosage: 80mcg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-01

Rebetol
    Administration route: Oral
    Start date: 2012-01-27
    End date: 2012-02-05

Rebetol
    Dosage: 200mg/2 day
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-21

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-01-26

Rebetol
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-06-12

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-05

Telavic
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-06-21

Other drugs received by patient: Urso 250



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Interstitial Lung Disease

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-03-30

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-29

PEG-Intron
    Dosage: 1.25mcg/kg/week
    Start date: 2012-02-03

PEG-Intron
    Dosage: 1.06mcg/kg/week
    Start date: 2012-01-26
    End date: 2012-05-31

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-02-24

PEG-Intron
    Dosage: once a week
    End date: 2012-01-25

Peginterferon Alfa-2B
    Dosage: 1.25 ?g/kg, qw
    Start date: 2012-02-03

Peginterferon Alfa-2B
    Dosage: 1.3 ?g/kg, qw

Peginterferon Alfa-2B
    Dosage: 1.56 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-02

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-01

Rebetol
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-05-31

Rebetol
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-05-17

Rebetol
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-02-23

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-29

Telavic
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-06

Telavic
    Administration route: Oral
    Start date: 2012-03-30

Other drugs received by patient: L Cartin; Epadel; Lendormin; Epadel S; Hange-Shashin-TO; Herbs (Unspecified); Urso 250; Lorfenamin; Mucosta; Urso 250; Lyrica



Possible Rebetol side effects in

Reported by a physician from Philippines on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, Fatigue, RED Blood Cell Count Decreased, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Start date: 2012-06-28

Rebetol
    Dosage: 800 mg, unk
    End date: 2012-08-02

Rebetol
    Dosage: 400 unk, unk
    Start date: 2012-08-02



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Anaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-06-05
    End date: 2012-06-25

PEG-Intron
    Dosage: 1.5mcg/kg
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

PEG-Intron
    Dosage: 50mcg/week
    Start date: 2012-06-26
    End date: 2012-07-09

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

Other drugs received by patient: Miglitol; Metformin HCL



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-24

Rebetol
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-24

Rebetol
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-06-14

Telavic
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-15

Telavic
    Administration route: Oral
    Start date: 2012-06-16
    End date: 2012-06-17

Other drugs received by patient: Iron Sucrose; Amlodipine Besylate; Enalapril Maleate; Bisoprolol Fumarate; Plavix; Trichlormethiazide; Aspirin; Basen OD; Perycit; Crestor



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Drug Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80mcg/week
    Indication: Hepatitis C
    Start date: 2012-04-09

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-20

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-09
    End date: 2012-05-13

Rebetol
    Administration route: Oral
    Start date: 2012-05-21

Telavic
    Administration route: Oral
    Start date: 2012-06-04

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-09
    End date: 2012-05-27

Telavic
    Administration route: Oral
    Start date: 2012-05-28
    End date: 2012-06-03

Other drugs received by patient: Selbex; Loxonin; Zolpidem; Alendronate Sodium; Voltaren; Loxonin; Rabeprazole Sodium; Urso 250



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Nausea, Brain Abscess, Blood Uric Acid Increased, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-16

PEG-Intron
    Dosage: 80 mcg/week
    Start date: 2012-01-16
    End date: 2012-05-07

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-16
    End date: 2012-04-22

Rebetol
    Dosage: 200 mg/2 days
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-04-14

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-02-26

Rebetol
    Dosage: 400 mg/2 days
    Administration route: Oral
    Start date: 2012-03-10
    End date: 2012-04-15

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-04-09

Other drugs received by patient: Carvedilol; Allegra; Carvedilol; Allegra; Diovan; Diovan; Naqua; [therapy Unspecified]; Trichlormethiazide



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-21

Patient:

Reactions: Haemoglobin Decreased, Hepatic Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8mcg/kg/week

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-24

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-04-25

Rebetol
    Administration route: Oral
    Start date: 2012-04-26

Telavic
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-06-01

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-05-13



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-20

Patient:

Reactions: Haemoglobin Decreased, Renal Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.8mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-05-13

PEG-Intron
    Dosage: 1.4mcg/kg/week
    Start date: 2012-05-14

Rebetol
    Administration route: Oral
    Start date: 2012-03-19
    End date: 2012-04-30

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-18

Rebetol
    Administration route: Oral
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-28

Telavic
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-07

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-04-23

Telavic
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-08

Other drugs received by patient: Ubiron; Rebamipide; Elieten; Losartan Potassium; Lendem D; Epadel S; Rebamipide; Bisoprolol Fumarate; Promac (Nitrofurantoin)



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-20

Patient:

Reactions: Haemoglobin Decreased, Anaemia

Drug(s) suspected as cause:
Depas
    Administration route: Oral
    Indication: Adverse Event
    Start date: 2012-05-08

Dogmatyl
    Administration route: Oral
    Indication: Adverse Event
    Start date: 2012-04-18
    End date: 2012-07-10

PEG-Intron
    Dosage: 1.63mcg/kg/week
    Start date: 2012-04-24
    End date: 2012-04-30

PEG-Intron
    Dosage: 1.08mcg/kg/week
    Start date: 2012-06-12

PEG-Intron
    Dosage: 2.0mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-04-23

PEG-Intron
    Dosage: 1.22mcg/kg/week
    Start date: 2012-05-01

PEG-Intron
    Dosage: 1.3mcg/kg/week
    End date: 2012-06-11

Rebetol
    Dosage: 200mg/every other day
    Administration route: Oral
    Start date: 2012-07-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-05-21

Rebetol
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-06-11

Telavic
    Dosage: 750 mg, once
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-06-11

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-06-04

Telavic
    Administration route: Oral
    Start date: 2012-06-12
    End date: 2012-06-18

Other drugs received by patient: Losartan Potassium and Hydrochlorothiazide



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-20

Patient:

Reactions: Haemoglobin Decreased, Skin Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 70g/kg/week
    Start date: 2012-05-16
    End date: 2012-05-16

PEG-Intron
    Dosage: 1.2g/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-09

PEG-Intron
    Dosage: 80g/kg/week
    Start date: 2012-05-23
    End date: 2012-06-13

Rebetol
    Administration route: Oral
    Start date: 2012-06-06
    End date: 2012-06-15

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-24

Rebetol
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-06-06

Telavic
    Administration route: Oral
    Start date: 2012-06-06
    End date: 2012-06-15

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-06-06

Other drugs received by patient: Detomefan; Urso 250; Vitamin E; Talion (Bepotastine Besylate); Marzulene-S; Huscode; Glakay; Mentax; Voltaren-XR



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-15

Patient:

Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-18

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Other drugs received by patient: Digoxin; Losartan Potassium and Hydrochlorothiazide; Warfarin Sodium; Bisoprolol Fumarate; Lasix; Coniel; Warfarin Sodium; Bisoprolol Fumarate; Losartan Potassium and Hydrochlorothiazide; Digoxin; Losartan Potassium and Hydrochlorothiazide; Lasix; Coniel



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.2mcg/kg/week
    Start date: 2012-06-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-20

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Start date: 2012-02-27
    End date: 2012-02-27

PEG-Intron
    Dosage: 0.9mcg/kg/week
    Start date: 2012-04-09
    End date: 2012-05-28

PEG-Intron
    Dosage: 0.9mcg/kg/week
    Start date: 2012-03-05
    End date: 2012-03-05

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Start date: 2012-03-12
    End date: 2012-04-02

Rebetol
    Administration route: Oral
    Start date: 2012-07-09

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-19

Rebetol
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-04-08

Rebetol
    Administration route: Oral
    Start date: 2012-04-09
    End date: 2012-04-22

Rebetol
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-07-08

Rebetol
    Administration route: Oral
    Start date: 2012-02-20
    End date: 2012-03-04

Rebetol
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-06-17

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-04-09

Other drugs received by patient: Famotidine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Anaemia, Platelet Count Decreased

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-04-26

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-05-01

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-25

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-04-20

PEG-Intron
    Dosage: 0.75mcg/kg/week
    Start date: 2012-06-01

PEG-Intron
    Dosage: 0.6mcg/kg/week
    Start date: 2012-04-27
    End date: 2012-04-27

PEG-Intron
    Dosage: 0.6mcg/kg/week
    Start date: 2012-05-18
    End date: 2012-05-25

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-04-12

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-26

Telavic
    Administration route: Oral
    Start date: 2012-05-25

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-04-26

Telavic
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-05-01

Other drugs received by patient: Miya BM; Taipemin; Allopurinol; Allopurinol; Lanizac; Valsartan and Hydrochlorothiazide; Urso 250; Sodium Ferrous Citrate; Ranitidine Hydrochloride; Valsartan and Hydrochlorothiazide; Bezafibrate; Bezafibrate; Allopurinol; Allopurinol



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Renal Impairment, Malaise, Anaemia, Rash, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 80 ?g, qw
    Start date: 2012-03-31

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-26

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-29

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-07-12

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-08

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-15
    End date: 2012-03-22

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-31
    End date: 2012-04-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-07

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-03-30

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-19
    End date: 2012-05-16

Rebetol
    Dosage: 400 mg, qd
    Start date: 2012-05-17
    End date: 2012-07-11

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-03-21

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-04-06

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-03-07

Other drugs received by patient: Clobetasol Propionate; Sedekopan; Nespo; Allopurinol; Nespo; Paxil; Celestamine TAB



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017